Medizinische Fakultät

Prof. Dr. med. Nisar Peter Malek

Director and Chair
Department of Internal Medicine I
University Hospital Tübingen

Otfried-Müller-Str. 10
72076 Tübingen, Germany

Phone: +49 (0)7071 29 82721
Fax: +49 (0)7071-29-2095

Email: Nisar.Malekspam

Download CV
10 most relevant publications

Professor Malek studied medicine at Hanover Medical University between 1989 and 1996, completing his doctorate with Professor Alfred Nordheim. After entering the Hospital for Gastroenterology, Hepatology and Endocrinology under the direction of Professor Michael P. Manns, he was trained as a specialist for internal medicine and as a gastroenterologist. Sponsored by the DFG, he spent three years – from 1998 to 2001 – doing research at the Fred Hutchinson Cancer Center in Seattle, USA, where he began his research work on molecular control of cell division. After returning to Hanover Medical University, his scientific work from 2002 to 2007 at the Institute for Molecular Biology of the MHH, under the direction of Professor Achim Gossler, was sponsored by the Max Eder Program of German Cancer Aid. In 2008, he was appointed to a W2 professorship within the framework of the REBIRTH excellence cluster of the DFG. Professor Malek has been the Medical Director of Medical Hospital 1 at the Tübingen University Clinical Centre since 2011. His clinical work mainly involves the treatment of malignant diseases of the gastrointestinal tract and liver along with therapy for patients with chronic liver diseases. The focus of his scientific work is decoding cell division mechanisms, with the goal of identifying new substances for treating tumour diseases. Professor Malek was honoured with the AIO Science Award in 2008 and the Johann Georg Zimmermann Prize for Cancer Research in 2009.

Research Interest

Joint Research Projects

2016 - 2019
i:DSem - Verbundprojekt „PersOnS - Personalisierte Onkologie durch Semantische Datenintegration“ Teilprojekt A , BMBF

2015 - 2018
FOR2314 „Targeting therapeutic windows in essential cellular processes for tumor therapy”, DFG

2017 - 2020
Else-Kröner-Fresenius-Forschungskolleg “Therapieresistenz solider Tumore“